Synovial Sarcoma - Online Patient Support Group


In the following article, Dr. Schwartz suggests Regorafenib may be active in synovial sarcoma:

His conclusion comes from the following European trial:

The results of the trial were presented at ASCO:

The study results were published in the Lancet:
The study protocol is here:

Side effects of Regorafenib are reported here: